A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma

Figure 6

Survival analysis of HCC patients based on the risk score and several immune checkpoint molecules. (a) Correlation analysis between risk score and several key immune-related molecules. (b–i) Two-factor survival analyses of risk score and immune checkpoint molecules including PDCD1 (b), CTLA4 (c), CD80 (d), CD86 (e), CD274 (f), PDCD1LG2 (g), CD276 (h), and VTCN1 (i).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)